Currently holds a position at Collegium Pharmaceutical Inc
Position | Company | Period |
---|---|---|
Executive Vice President, General Counsel, Secretary | Collegium Pharmaceutical Inc | March 16, 2018 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-06-28 | 2023-06-26 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
1,363
-1.1%
22.5330,715 USD |
1,363 -1.1% | 22.53 | 30,715 USD | |
2023-06-28 | 2023-06-26 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
16,621
-12.1%
21.65359,918 USD |
16,621 -12.1% | 21.65 | 359,918 USD | |
2022-09-16 | 2022-09-15 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
38,589
-26.1%
18.07697,303 USD |
38,589 -26.1% | 18.07 | 697,303 USD | |
2022-08-15 | 2022-08-11 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
300
-0.2%
20.016,003 USD |
300 -0.2% | 20.01 | 6,003 USD | |
2021-05-12 | 2021-05-10 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
7,000
-7.2%
22.77159,390 USD |
7,000 -7.2% | 22.77 | 159,390 USD | |
2021-01-21 | 2021-01-20 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
6,081
-5.5%
24.45148,680 USD |
6,081 -5.5% | 24.45 | 148,680 USD | |
2020-10-16 | 2020-10-15 |
Collegium Pharmaceutical Inc
(COLL)
|
PS Planned sale |
7,060
-10.9%
20.82146,989 USD |
7,060 -10.9% | 20.82 | 146,989 USD |